Participants in the Jessilove subsidiary program can be assured we follow all HIPAA guidelines. Jessilove is
committed to advancing Medical Cannabis as mainstream treatment options. Any information shared in
a research capacity will also follow HIPAA guidelines and not include your personal information. Data such
as specific diagnosis, cannabis consumption, preferred modes of transmission, efficacy of strains and
products. This information is vital for both the Cannabis Industry and Medical Professionals. We thank
you for your participation in this program and hope that by collecting and sharing this data we will both
advance the Medical Cannabis movement and assist Canna Growers and Processors in developing more
diagnosis specific treatments.